The Valuation Paradox
How do you put a price on something that doesn't generate revenue yet? This is the fundamental challenge of early-stage fundraising. The truth is, pre-revenue valuations are more art than science — but there are frameworks that help.
Method 1: Comparable Deals
Look at what similar startups raised at your stage. If AI startups in your space are raising $2M seeds at $10M post-money, that's your starting benchmark. Platforms like theVeeCee can surface recent comparable deals to anchor your expectations.
Method 2: The Berkus Method
Assign value to five risk factors: sound idea ($500K), working prototype ($500K), quality team ($500K), strategic relationships ($500K), and product rollout/sales ($500K). A perfect score gives you a $2.5M pre-money valuation. Adjust each factor based on your actual progress.
Method 3: Reverse Engineering from Dilution
Most seed rounds involve 15–25% dilution. If you need $1M and want to give up no more than 20%, your post-money valuation is $5M. This method starts from what you're willing to give up and works backward.
What Actually Drives Pre-Revenue Valuation
Investors at this stage are pricing four things:
- Team: Repeat founders or domain experts command premiums.
- Market size: Bigger addressable markets justify higher valuations.
- Traction signals: Waitlists, LOIs, partnerships, or pilot agreements.
- Competitive dynamics: If multiple investors want in, your valuation goes up.
The Biggest Mistake
Don't optimize for the highest possible valuation. An inflated seed valuation creates a "valuation trap" where you need unrealistic growth to justify your Series A price. A reasonable valuation that leaves room for a clean markup is far healthier for your company long-term.